Press release
Non-Small Cell Lung Cancer Pipeline Therapeutic H1 2017
For More on Non-Small Cell Lung Cancer Pipeline Review H1 2017 Report Inquire @
https://tinyurl.com/Non-Small-Cell-Lung-Cancer .
Report Description:
The Non-Small Cell Lung Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Small Cell Lung Cancer Pipeline and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 8, 49, 192, 176, 1, 11, 173, 20 and 11 respectively. Similarly, the Universities portfolio in Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages comprises 13, 11, 1, 40 and 4 molecules, respectively. Pharmaceutical and Healthcare latest pipeline guide Non-Small Cell Lung Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Non-Small Cell Lung Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
This Report Available with Discount @ https://tinyurl.com/NSLC-Drugs .
Non-Small Cell Lung Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Report Analyzes Non-Small Cell Lung Cancer Pipeline by Companies Including:
3-V Biosciences Inc, 3SBio Inc, 4SC AG, AbbVie Inc, Ability Pharmaceuticals SL, ACEA Biosciences Inc, Adamed Sp z oo, Adaptimmune Therapeutics Plc, Advantagene Inc, Advaxis Inc, Advenchen Laboratories LLC, Allist Shanghai Pharmaceutical Technology Co Ltd, Altimmune Inc, Altor BioScience Corp, Amgen Inc, Andarix Pharmaceuticals Inc, AndroScience Corp, Apexigen Inc, Aptose Biosciences Inc, Argos Therapeutics Inc, Ariad Pharmaceuticals Inc, ARMO Biosciences Inc, Arog Pharmaceuticals Inc, ArQule Inc, Array BioPharma Inc, Arrien Pharmaceuticals LLC, Asana BioSciences LLC, Astellas Pharma Inc, Asterias Biotherapeutics Inc, Astex Pharmaceuticals Inc, AstraZeneca Plc, Atreca Inc, Aurigene Discovery Technologies Ltd, Aurobindo Pharma Ltd, AVEO Pharmaceuticals Inc, Axelar AB, Basilea Pharmaceutica Ltd, Batu Biologics Inc, Bavarian Nordic A/S, Bayer AG, BeiGene (Beijing) Co Ltd, Beijing Hanmi Pharmaceutical Co Ltd, BerGenBio ASA, Beta Pharma Inc, Betta Pharmaceuticals Co Ltd, BeyondSpring Pharmaceuticals Inc, Bicycle Therapeutics Ltd, Bio-Path Holdings Inc, Biocad, BioCancell Ltd, Biocon Ltd, BioLineRx Ltd, Bionovis SA, Biothera Pharmaceutical Inc, Blueprint Medicines Corp, Boehringer Ingelheim GmbH, Boston Biomedical Inc, Bristol-Myers Squibb Company, Calithera Biosciences Inc, CanBas Co Ltd, Cantargia AB, Cascadian Therapeutics Inc, CASI Pharmaceuticals Inc, CBT Pharmaceuticals Inc, Celgene Corp, CellAct Pharma GmbH, Celldex Therapeutics Inc, Cellectar Biosciences Inc, Cellmid Ltd, Cellular Biomedicine Group Inc, Chipscreen Biosciences Ltd, Chugai Pharmaceutical Co Ltd, Cielo Therapeutics Inc, Cipla Ltd, Cleave Biosciences Inc, Coherus BioSciences Inc, Corcept Therapeutics Inc, Cortice Biosciences Inc, Corvus Pharmaceuticals Inc, Critical Outcome Technologies Inc, CSPC Pharmaceutical Group Limited, CytImmune Sciences Inc, CytomX Therapeutics Inc, Cytori Therapeutics Inc, CytRx Corp, DAE HWA Pharmaceutical Co Ltd, Daiichi Sankyo Company Ltd, DanDrit Biotech A/S, Debiopharm International SA, DEKK-TEC Inc, DelMar Pharmaceuticals Inc, Denovo Biopharma LLC, Domainex Ltd, Double Bond Pharmaceutical International AB, Dr. Reddy's Laboratories Ltd, Dynavax Technologies Corp, Eagle Pharmaceuticals Inc, Eisai Co Ltd, Eleison Pharmaceuticals LLC, Eli Lilly and Company, Endocyte Inc, EnGeneIC Ltd, EntreChem SL, Enumeral Biomedical Holdings Inc, EpiThany Inc, Etubics Corp, Eudendron Srl, Evotec AG, Exelixis Inc, F. Hoffmann-La Roche Ltd, FibroStatin SL, Five Prime Therapeutics Inc, Formosa Laboratories Inc, Fujifilm Corp, G&E Herbal Biotechnology Co Ltd, G1 Therapeutics Inc, Galectin Therapeutics Inc, Gene Techno Science Co Ltd, Genelux Corp, Genentech Inc, Genmab A/S, Genocea Biosciences Inc, Genor BioPharma Co Ltd, Genosco Inc, Genzyme Corp, Gilead Sciences Inc, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd, Globeimmune Inc, GlycaNova Norway AS, Glycotope GmbH, Golden Biotechnology Corp, Gradalis Inc, GreenPeptide Co Ltd, Griffith University, Grunenthal GmbH, Halozyme Therapeutics Inc, Hanmi Pharmaceuticals Co Ltd, Heat Biologics Inc, Helix BioPharma Corp, Hemispherx Biopharma Inc, Heptares Therapeutics Ltd, HitGen LTD, Horizon Pharma Plc, Humorigin Biotechnology Corp, Hutchison China MediTech Ltd, iCeutica Inc, Ideaya Biosciences Inc, Ignyta Inc, Immune Design Corp, Immune Pharmaceuticals Inc, ImmunGene Inc, Immunocore Ltd, ImmunoGen Inc, Immunomedics Inc, Incyte Corp, Infinity Pharmaceuticals Inc, Inflection Biosciences Ltd, Innovation Pharmaceuticals Inc, Innovent Biologics Inc, Inovio Pharmaceuticals Inc, Intas Pharmaceuticals Ltd, Invectys SA, Inventiva, IO Biotech ApS, Io Therapeutics Inc, Ionis Pharmaceuticals Inc, JHL Biotech Inc, Jiangsu Hansoh Pharmaceutical Group Co Ltd, Jiangsu Hengrui Medicine Co Ltd, Jiangsu Kanion Pharmaceutical Co Ltd, Johnson & Johnson, Jounce Therapeutics Inc, Juno Therapeutics Inc, Kadmon Corp LLC, Karyopharm Therapeutics Inc, Kite Pharma Inc, Komipharm International Co Ltd, Kura Oncology Inc, Kyowa Hakko Kirin Co Ltd, LATITUDE Pharmaceuticals Inc, Leap Therapeutics Inc, Les Laboratoires Servier SAS, Lion Biotechnologies Inc, Lipopharma Therapeutics SL, Loxo Oncology Inc, Mabion SA, MacroGenics Inc, Mallinckrodt Plc, Mebiopharm Co Ltd, MedImmune LLC, Merck & Co Inc, Merck KGaA, Merrimack Pharmaceuticals Inc, Mersana Therapeutics Inc, Merus NV, Microlin Bio Inc, Millennium Pharmaceuticals Inc, Mirati Therapeutics Inc, Molecular Partners AG, MolMed SpA, Morphotek Inc, Multimmune GmbH, Mycenax Biotech Inc, NanoCarrier Co Ltd, NantKwest Inc, Natco Pharma Ltd, Nektar Therapeutics, Neumedicines Inc, NewLink Genetics Corp, Northwest Biotherapeutics Inc, Novartis AG, Oncobiologics Inc, Oncogenex Pharmaceuticals Inc, Oncolys BioPharma Inc, Oncolytics Biotech Inc, OncoMed Pharmaceuticals Inc, Ono Pharmaceutical Co Ltd, Onxeo SA, Optimum Therapeutics LLC, Oribase Pharma, OSE Immunotherapeutics, Oxford BioTherapeutics Ltd, Peregrine Pharmaceuticals Inc, Pfizer Inc, Pharma Mar SA, Philogen SpA, Phosplatin Therapeutics LLC, Plexxikon Inc, Polaris Pharmaceuticals Inc, Provectus Biopharmaceuticals Inc, PsiOxus Therapeutics Ltd, Puma Biotechnology Inc, Purdue Pharma LP, Qilu Pharmaceutical Co Ltd, Qu Biologics Inc, Quintessence Biosciences Inc, Qurient Co Ltd, Rafael Pharmaceuticals Inc, Reata Pharmaceuticals Inc, Recombio SL, Regeneron Pharmaceuticals Inc, Rexahn Pharmaceuticals Inc, Rgenix Inc, Richter Gedeon Nyrt, Samyang Holdings Corp, Sanofi, Scancell Holdings Plc, SciClone Pharmaceuticals Inc, ScinoPharm Taiwan Ltd, Seattle Genetics Inc, Selvita SA, Shanghai Fosun Pharmaceutical (Group) Co Ltd, Shanghai Pharmaceutical Co Ltd, Shionogi & Co Ltd, Sierra Oncology Inc, Sigma-Tau SpA, SignPath Pharma Inc, Simcere Pharmaceutical Group, Sotio AS, Spotlight Innovation Inc, Starpharma Holdings Ltd, Sumitomo Dainippon Pharma Co Ltd, SuviCa Inc, Symic Biomedical Inc, Symphogen A/S, Synactix Pharmaceuticals Inc, Syndax Pharmaceuticals Inc, Synermore Biologics Co Ltd, Systimmune Inc, Taiho Pharmaceutical Co Ltd, Takara Bio Inc, Tasly Pharmaceutical Group Co Ltd, TC BioPharm Ltd, Teva Pharmaceutical Industries Ltd, Tocagen Inc, Tolero Pharmaceuticals Inc, TRACON Pharmaceuticals Inc, Transgene SA, Trovagene Inc, Tyme Technologies Inc, UbiVac LLC, Ultimovacs AS, United BioPharma Inc, Vaccinex Inc, VasGene Therapeutics Inc, Vault Pharma Inc, Vaxon Biotech, Verastem Inc, VG Life Sciences Inc, ViiV Healthcare Ltd, Viralytics Ltd, XBiotech Inc, XuanZhu Pharma Co Ltd, Yooyoung Pharm Co Ltd, Zensun (Shanghai) Sci & Tech Co Ltd, Zydus Cadila Healthcare Ltd, Zymeworks Inc.
Scope:
-The pipeline guide provides a snapshot of the global therapeutic landscape of Non-Small Cell Lung Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Non-Small Cell Lung Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Non-Small Cell Lung Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Non-Small Cell Lung Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Non-Small Cell Lung Cancer (Oncology).
Purchase This Report at: https://tinyurl.com/Therapeutics-Development .
Major Table of Content:
• Introduction
• Non-Small Cell Lung Cancer - Overview
• Non-Small Cell Lung Cancer - Therapeutics Development
• Non-Small Cell Lung Cancer - Therapeutics Assessment
• Non-Small Cell Lung Cancer - Companies Involved in Therapeutics Development
• Non-Small Cell Lung Cancer - Drug Profiles
• Non-Small Cell Lung Cancer - Dormant Projects
• Non-Small Cell Lung Cancer - Discontinued Products
• Non-Small Cell Lung Cancer - Product Development Milestones.
Reportsnreports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries
Ritesh Tiwari
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
India.
Tel: + 1 888 391 5441
E-mail: sales@reportsnreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Small Cell Lung Cancer Pipeline Therapeutic H1 2017 here
News-ID: 612717 • Views: …
More Releases from ReportsandReports
The Growing Importance of Smart Wearable Equipment - Global Market: Today's Worl …
The report presents detailed information regarding the prominent players and potential competitors in the Smart Wearable Equipment - Global market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player.
This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses…
Vegetable Glycerin - Global Market 2023 Driving Factors Forecast Research 2029
This comprehensive report thoroughly assesses various regions, estimating the volume of the global Vegetable Glycerin - Global market within each region during the projected timeframe. The report is meticulously crafted and includes valuable information on the current market status, historical data, and projected outlook. Furthermore, it presents a detailed market analysis, segmenting it based on regions, types, and applications. The report closely monitors key trends that play a crucial role…
Underground Concrete - Global Market Booming Worldwide with Latest Trend and Fut …
The report presents detailed information regarding the prominent players and potential competitors in the Underground Concrete - Global market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player.
This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue,…
Eucalyptol - Global Market was Led by the Solution Category
This comprehensive report thoroughly assesses various regions, estimating the volume of the global Eucalyptol - Global market within each region during the projected timeframe. The report is meticulously crafted and includes valuable information on the current market status, historical data, and projected outlook. Furthermore, it presents a detailed market analysis, segmenting it based on regions, types, and applications. The report closely monitors key trends that play a crucial role in…
More Releases for Pharm
Fosfomycin Market to Witness Huge Growth by 2026 | Northeast Pharm, Ercros, Shin …
The Latest Released Fosfomycin market study has evaluated the future growth potential of Global Fosfomycin market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities…
Clopidol Market updates, demand analysis, and expected growth forecast 2021-2027 …
Global “Clopidol” Market Size, Status, and Forecast 2021-2027. In-depth research accumulated to offer Latest insights about acute features of the global Clopidol market. This report provides a detailed overview of key factors in the Clopidol Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The effect of the COVID-19 outbreak at the enterprise turned into completely assessed. Fully chance evaluation and enterprise recommendations…
Paromomycin Market updates, demand analysis, and expected growth forecast 2021-2 …
The new study on the Global “Paromomycin Market” 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the Paromomycin industry. Because of the in-depth overview of the Global Paromomycin market, the recent papers allow investors, traders, and manufacturers to plan some innovative techniques, and meanwhile, align them with operational and commercial enterprise models. Additionally, the Paromomycin market report offers crucial facets at the…
Clopidol Market updates, demand analysis and expected growth forecast 2021-2027 …
The “Clopidol” Market report mainly studies the size, recent trends, and development status of the Clopidol market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain, and competitive landscape. Technological innovation and advancement will further enhance the performance of the product, making it more broadly used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for…
Perphenazine Market Overall Study Report 2020-2027 | Players Sandoz, Actavis, Qu …
The latest report added by Stratagem Market Insights gives deep insights into the drivers and restraints in the Worldwide Perphenazine Market. The research report "Global Perphenazine Market Size and Growth Forecast to 2027" provide a comprehensive take on the overall market. Analysts have carefully evaluated the milestones achieved by the global Perphenazine market and the current trends that are likely to shape its future. Primary and secondary research methodologies have…
Global Polygeline Injection Market Forecast 2018-2025 Abbott, Shengtai Pharm, BB …
A detailed market study on "Global Polygeline Injection Market" examines the performance of the Polygeline Injection market. It encloses an in-depth Research of the Polygeline Injection market state and the competitive landscape globally. This report analyzes the potential of Polygeline Injection market in the present and the future prospects from various angles in detail.
The Global Polygeline Injection Market 2018 report includes Polygeline Injection market Revenue, market Share, Polygeline Injection industry…
